| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.0M | -68.8% |
| SG&A Expense | $6.3M | -35.4% |
| Pre-tax Income | -$6.0M | -8.3% |
| Net Income | -$6.0M | -8.3% |
| EPS (Basic) | -$1.18 | -245.7% |
| EPS (Diluted) | -$1.18 | -245.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.7M | -23.5% |
| Current Assets | $30.5M | -20.9% |
| Total Assets | $31.1M | -19.4% |
| Current Liabilities | $4.3M | +225.7% |
| Total Liabilities | $5.5M | +73.2% |
| Stockholders' Equity | $24.3M | -25.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | +53.9% |
| Capital Expenditures | $3K | -63.5% |
| Investing Cash Flow | -$2.0M | — |
| Financing Cash Flow | -$1.6M | -111.3% |
| Free Cash Flow | -$5.2M | +53.9% |